Published in Clinical Oncology Week, April 4th, 2005
In a recent study from Italy, the "incidence of fungal infections and the role of liposomal amphotericin B (Ambisome) in proven and probable infections were evaluated in acute leukemic patients, intolerant to conventional amphotericin B."
"During 1999-2002, 307 febrile episodes occurred in 231 patients," noted R. Fanci and coauthors working at Careggi Hospital in Florence. "Fungi were responsible for 3% of bloodstream infections."
"Ambisome was employed in five fungal sepsis (one Candida albicans,...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Clinical Oncology Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.